Cargando…
Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease
BACKGROUND: Alzheimer’s disease (AD) is the most common neurodegenerative disease ultimately manifesting as clinical dementia. Despite considerable effort and ample experimental data, the role of neuroinflammation related to systemic inflammation is still unsettled. While the implication of microgli...
Autores principales: | Munawara, Usma, Catanzaro, Michael, Xu, Weili, Tan, Crystal, Hirokawa, Katsuiku, Bosco, Nabil, Dumoulin, David, Khalil, Abdelouahed, Larbi, Anis, Lévesque, Simon, Ramassamy, Charles, Barron, Annelise E., Cunnane, Stephen, Beauregard, Pascale B., Bellenger, Jean-Pierre, Rodrigues, Serafim, Desroches, Mathieu, Witkowski, Jacek M., Laurent, Benoit, Frost, Eric H., Fulop, Tamas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215492/ https://www.ncbi.nlm.nih.gov/pubmed/34154615 http://dx.doi.org/10.1186/s12979-021-00236-x |
Ejemplares similares
-
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
por: Fulop, Tamas, et al.
Publicado: (2021) -
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
por: Fulop, Tamas, et al.
Publicado: (2022) -
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
por: Fulop, Tamas, et al.
Publicado: (2018) -
Are We Ill Because We Age?
por: Fulop, Tamas, et al.
Publicado: (2019) -
Immunosupportive therapies in aging
por: Fülöp, Tamas, et al.
Publicado: (2007)